Showing results (1-10 of 990) with videos related to
Sort By:
Pageof 99
International Journal of Clinical Oncology|April 25, 2009
Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trialsQian Shi, Daniel J SargentClinical Advances in Hematology & Oncology : H&O|September 10, 2015
Key statistical concepts in cancer researchQian Shi, Daniel J SargentSeminars in Oncology|August 4, 2011
Statistical considerations for the next generation of clinical trialsWenting Wu, Qian Shi, Daniel J SargentScandinavian Journal of Gastroenterology|December 21, 2011
Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trialsQian Shi, Sumithra J Mandrekar, Daniel J SargentChinese Clinical Oncology|April 6, 2015
Mining the ACCENT database: a review and updateLindsay A Renfro, Qian Shi, Daniel J SargentJournal of Biopharmaceutical Statistics|April 28, 2017
A hierarchical Bayesian design for randomized Phase II clinical trials with multiple groupsJun Yin, Rui Qin, Daniel J Sargent, et al.Statistics in Medicine|December 14, 2011
Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trialsLindsay A Renfro, Qian Shi, Daniel J Sargent, et al.Computational Statistics & Data Analysis|July 26, 2014
Center-Within-Trial Versus Trial-Level Evaluation of Surrogate EndpointsLindsay A Renfro, Qian Shi, Yuan Xue, et al.Clinical Colorectal Cancer|January 27, 2015
Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data AnalysisSharlene Gill, Jean-Francois Haince, Qian Shi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial)Dan Sha, Adam M Lee, Qian Shi, et al.Pageof 99